You have no items in your shopping cart.
ABSTRACT
A cross sectional study was conducted to access the quality of life and ocular surface disease in 100 glaucoma patients who were on topical anti-glaucoma medication and 24 glaucoma suspects. The OSDI and GQL-15 questionaires were employed for this study. Statistical Package for Social Sciences (SPSS) version 22.0 was used to analyze the data. The OSDI scores had a positive correlation with GQL-15 scores using the Spearman correlation coefficient (P<0.01). On univariate analysis, OSDI score correlated with increasing age (Mean of 62.6±16.4), number of anti-glaucoma medications (Mean of 64.4±17.0) and their duration (mean of 63.2±13.7). Also the GQL-15 score on univariate analysis had a positive correlation with increased age (Mean of 54.5±13.5), the number of anti-glaucoma medications (56.7±12.5) and their duration (Mean of 55.1±11.4). Therefore, it was concluded that ocular surface disease is more severe in glaucoma patients with increased age, number and duration of anti-glaucoma topical medications and consequently leads to a reduced quality of life.
